Preparations containing glycated chitosan in a physiologically compatible carrier are described. Viscoelastic preparations comprise 1.0-12.0 percent by weight of glycated chitosan in an aqueous solution while lower viscosity solutions possess 0.1-0.5 percent by weight glycated chitosan. The otherwise free amino groups of the chitosan polymer are preferably 30-90% glycated and possess an average molecular weight of between 100,000 and 2,000,000 Daltons, and, most preferably between 100,000 and 1,000,000 Daltons.

 
Web www.patentalert.com

< Use of lipid conjugates in the treatment of infection

< Use of lipid conjugates in the treatment of infection

> Recombinant expression of streptococcus pyogenes cysteine protease and immunogenic compositions thereof

> Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies

~ 00285